机译:靶向DnaN的新型灰霉素治疗结核病
Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany|German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany;
Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany|German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany|Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany;
Johns Hopkins Univ, Ctr TB Res, Sch Med, Baltimore, MD 21231 USA|KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, South Africa;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany|German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany;
Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany|German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany;
Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany|German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Johns Hopkins Univ, Ctr TB Res, Sch Med, Baltimore, MD 21231 USA|KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, South Africa;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Sanofi Aventis R&D, Strategy Sci Policy & External Innovat S&I, F-75008 Paris, France;
Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany|Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, D-65926 Frankfurt, Germany;
German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany|Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Sanofi Aventis R&D, Disposit Safety & Anim Res, F-34184 Montpellier, France;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany;
Johns Hopkins Univ, Ctr TB Res, Sch Med, Baltimore, MD 21231 USA;
Johns Hopkins Univ, Ctr TB Res, Sch Med, Baltimore, MD 21231 USA;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Johns Hopkins Univ, Ctr TB Res, Sch Med, Baltimore, MD 21231 USA|KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, South Africa;
Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France;
Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany|German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany;
机译:生物合成含甲基脯氨酸,含有抗结核活性的天然产物
机译:生物合成含甲基脯氨酸,含有抗结核活性的天然产物
机译:新的格林霉素治疗结核病
机译:激光疗法在治疗肺结核作为化学疗法的辅助治疗失败病例中的作用
机译:在结核分枝杆菌中靶向Enoyl-ACP还原酶:时间依赖性抑制和靶标参与的细胞后果的机制。
机译:含甲基脯氨酸的格林霉素(具有抗结核活性的天然产物)的生物合成
机译:含有甲基脯氨酸的格林霉素(一种具有抗结核活性的天然产物)的生物合成。